XML 46 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 02, 2015
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:            
Net loss   $ (1,428,040) $ (1,897,328) $ (2,002,136) $ (3,223,868)  
Adjustments to reconcile net loss to net cash used by operating activities            
Depreciation and amortization       24,573 $ 15,313  
Amortization of issuance costs       $ 60,486    
Fair value of common stock issued for consulting         $ 178,160  
Share-based compensation related to employee stock options       $ 150,570 236,953  
Loss on intangible asset dispositions         16,591  
Net loss on sale of trading securities       $ 11,946 302,116  
Change in unrealized gain (loss) on trading securities       (7,986) (236,143)  
Loss on revaluation and modification of derivative warrant liability       274,024 706,967  
(Increase) decrease in:            
Prepaid expenses & other       20,897 (103,818)  
Increase (decrease) in:            
Accounts payable       606,631 586,100  
Accrued expenses & other       79,737 (26,278)  
Net Cash Used in Operating Activities       (781,258) (1,547,907)  
CASH FLOWS FROM INVESTING ACTIVITIES:            
Proceeds from sale of investments       $ 35,970 568,852  
Cash paid for intangible assets         (350,000)  
Cash paid for purchase of property and equipment         (6,564)  
Net Cash Provided by Investing Activities       $ 35,970 $ 212,288  
CASH FLOWS FROM FINANCING ACTIVITIES:            
Proceeds from issuance of convertible notes payable - short term       600,000    
Notes payable issuance costs       (54,815)    
Repayment of notes payable $ (3,542)     $ (10,000)    
Proceeds from the exercise of stock warrants         $ 90,375  
Proceeds from sale of common stock, net         203,055  
Net Cash Provided by Financing Activities       $ 535,185 293,430  
Net Decrease in Cash and Cash Equivalents       (210,103) (1,042,189)  
Cash and Cash Equivalents, Beginning of Period $ 42,042     252,145 1,143,175 $ 1,143,175
Cash and Cash Equivalents, End of Period   $ 42,042 $ 100,986 $ 42,042 $ 100,986 $ 252,145
Supplemental Cash Flow Disclosures:            
Interest expense paid in cash            
Tax paid         $ 1,683  
Supplemental Non-Cash Disclosure:            
Fair value of warrants modified in connection with Series B financing         (114,923)  
Fair value of warrants issued to Series B placement agents         (12,738)  
Series B Preferred Stock dividends accrued       $ (248,503) (225,219)  
Series A Preferred Stock dividend       (34,685) (38,666)  
Conversion of Series A Preferred Stock dividend to Common Stock       $ (4,329) (16,068)  
Conversion of Series A preferred shares to Common Stock         (1,254)  
Conversion of preferred shares and accrued dividends to Common Stock         $ (1,254)  
Series B Preferred Stock [Member]            
Supplemental Non-Cash Disclosure:            
Conversion of Series A Preferred Stock dividend to Common Stock       $ (1,220)    
Conversion of Series A preferred shares to Common Stock       (75)   $ (1,373)
Conversion of preferred shares and accrued dividends to Common Stock       $ (75)   $ (1,373)